Sandra Vranic

Sandra Vranic

Auto-generated profile, based on publicly available information

Sandra Vranic

Nano-Cell Biology Lab, Division of Cell Matrix Biology & Regenerative Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2017 in Nature Nanotechnology
Verified
Journal Article
Closed access
DMDaryl McManus
Daryl McManus
SVSandra Vranic
Sandra Vranic
FWFreddie Withers
Freddie Withers
VSVeronica Sanchez-Romaguera
Veronica Sanchez-Romaguera
MMMassimo Macucci
Massimo Macucci
CCCinzia Casiraghi
Cinzia Casiraghi

1 January 2020 in Theranostics
Verified
Journal Article
Open access
LFLaura Fusco
Laura Fusco
Arianna GazziArianna Gazzi
Arianna Gazzi
Guotao PengGuotao Peng
Guotao Peng
YSYuyoung Shin
Yuyoung Shin
SVSandra Vranic
Sandra Vranic
LDLucia Gemma Delogu
Lucia Gemma Delogu
Cancer represents one of the main causes of death in the world; hence the development of more specific approaches for its diagnosis and treatment is urgently needed in clinical practice. Here we aim at providing a comprehensive review on the use of 2-dimensional materials (2DMs) in cancer theranostics. In particular, we focus on graphene-related materials (GRMs), graphene hybrids, and graphdiyne (GDY), as well as other emerging 2DMs, such as MXene, tungsten disulfide (WS2), molybdenum disulfide (MoS2), hexagonal boron nitride (h-BN), black phosphorus (BP), silicene, antimonene (AM), germanene, biotite (black mica), metal organic frameworks (MOFs), and others. The results reported in the scientific literature in the last ten years (>200 papers) are dissected here with respect to the wide variety of combinations of imaging methodologies and therapeutic approaches, including drug/gene delivery, photothermal/photodynamic therapy, sonodynamic therapy, and immunotherapy. We provide a unique multidisciplinary approach in discussing the literature, which also includes a detailed section on the characterization methods used to analyze the material properties, highlighting the merits and limitations of the different approaches. The aim of this review is to show the strong potential of 2DMs for use as cancer theranostics, as well as to highlight issues that prevent the clinical translation of these materials. Overall, we hope to shed light on the hidden potential of the vast panorama of new and emerging 2DMs as clinical cancer theranostics.

13 February 2024 in ACS Nano
Verified
Journal Article
Open access
HLHazel Lin
Hazel Lin
TBTina Buerki-Thurnherr
Tina Buerki-Thurnherr
JKJasreen Kaur
Jasreen Kaur
PWPeter Wick
Peter Wick
MPMarco Pelin
Marco Pelin
Alberto BiancoAlberto Bianco
Alberto Bianco
Two-dimensional (2D) materials have attracted tremendous interest ever since the isolation of atomically thin sheets of graphene in 2004 due to the specific and versatile properties of these materials. However, the increasing production and use of 2D materials necessitate a thorough evaluation of the potential impact on human health and the environment. Furthermore, harmonized test protocols are needed with which to assess the safety of 2D materials. The Graphene Flagship project (2013-2023), funded by the European Commission, addressed the identification of the possible hazard of graphene-based materials as well as emerging 2D materials including transition metal dichalcogenides, hexagonal boron nitride, and others. Additionally, so-called green chemistry approaches were explored to achieve the goal of a safe and sustainable production and use of this fascinating family of nanomaterials. The present review provides a compact survey of the findings and the lessons learned in the Graphene Flagship.

29 December 2017 in ACS Nano
Verified
Journal Article
Open access
SVSandra Vranic
Sandra Vranic
ARArtur Filipe Rodrigues
Artur Filipe Rodrigues
MBMaurizio Buggio
Maurizio Buggio
LNLeon Newman
Leon Newman
MWMichael R. H. White
Michael R. H. White
KKKostas Kostarelos
Kostas Kostarelos
The interest in graphene and its translation into commercial products have been expanding at high pace. In regard to previously described pulmonary safety concerns for carbon nanomaterials, there is a great need to define parameters guiding interactions between graphene-based materials and pulmonary system. The aim of present study was to determine the importance of two critical parameters: lateral dimensions of the material and coating with proteins in relation to each other and their pulmonary impact. Endotoxin-free materials with distinct lateral dimensions – s-GO (50 – 200 nm) and l-GO (5 – 15 µm) were produced and thoroughly characterized. Exploiting intrinsic fluorescence of GO and using confocal live-cell imaging, we visualized the behavior of the cells in response to the material in real time. Although BEAS-2B cells internalized GO efficiently, l-GO was linked to higher plasma membrane interactions correlated with elevated ROS levels, pro-inflammatory response and greater cytotoxicity, in agreement with the oxidative stress paradigm. For both GO types, the presence of serum alleviated lipid peroxidation of plasma membrane and decreased intracellular ROS levels. However, protein coating was not enough to entirely mitigate toxicity and inflammatory response induced by l-GO. In vitro results were validated in vivo, as l-GO was more prone to induce pulmonary granulomatous response in mice compared to s-GO. In conclusion, lateral dimension of GO played more important role than serum protein coating in determining biological responses to the material. It was also demonstrated that time-lapse imaging of live cells interacting with label-free GO sheets can be used as a tool to assess GO induced cytotoxicity.

16 November 2018 in ACS Nano
Verified
Journal Article
Open access
CHChristopher Hoyle
Christopher Hoyle
JRJack Rivers-Auty
Jack Rivers-Auty
ELEloïse Lemarchand
Eloïse Lemarchand
SVSandra Vranic
Sandra Vranic
EWEmily Wang
Emily Wang
DBDavid Brough
David Brough
Graphene oxide (GO), an oxidized form of graphene, has potential applications in biomedical research. However, how GO interacts with biological systems, including the innate immune system, is poorly understood. Here we elucidate the effects of GO sheets on macrophages, identifying distinctive effects of GO on inflammatory phenotype. Small, thin (s) GO dose-dependently inhibited release of interleukin (IL)-1β and IL-6, but not tumor necrosis factor (TNF)-α. NLRP3 inflammasome and caspase 1 activation was not affected. The effect of s-GO was pre-translational, as s GO blocked Toll-like receptor 4 dependent expression of Il1b and Il6, but not Nlrp3 or Tnf mRNA transcripts. s-GO was internalized by immortalized bone marrow-derived macrophages, suggesting a potential intracellular action. Uptake of polystyrene beads with similar lateral dimensions and surface charge did not phenocopy the effects of s GO, suggesting that s-GO-mediated inhibition of interleukin expression was not simply due to particle phagocytosis. RNA-Seq analysis established that s-GO had profound effects on the immunometabolism of the cells, leading to activation of the transcription factor nuclear factor erythroid 2-related factor 2 (NRF2), which inhibited expression of cytokines such as IL 1β and IL-6. Thus, we have identified immunometabolic effects of GO that reveal another dimension to its effects on cells. These findings suggest that s-GO may be used as a valuable tool to generate further insights into inflammatory mechanisms, and inform its potential applications in biomedicine.

Verified
Journal Article
Open access
PDF file
SVSandra Vranic
Sandra Vranic
Yasuhito ShimadaYasuhito Shimada
Yasuhito Shimada
SISahoko Ichihara
Sahoko Ichihara
MKMasayuki Kimata
Masayuki Kimata
WWWenting Wu
Wenting Wu
GIGaku Ichihara
Gaku Ichihara
As the use of nanoparticles (NPs) is increasing, the potential toxicity and behavior of NPs in living systems need to be better understood. Our goal was to evaluate the developmental toxicity and bio-distribution of two different sizes of fluorescently-labeled SiO2 NPs, 25 and 115 nm, with neutral surface charge or with different surface functionalization, rendering them positively or negatively charged, in order to predict the effect of NPs in humans. We performed a zebrafish embryo toxicity test (ZFET) by exposing the embryos to SiO2 NPs starting from six hours post fertilization (hpf). Survival rate, hatching time, and gross morphological changes were assessed at 12, 24, 36, 48, 60, and 72 hpf. We evaluated the effect of NPs on angiogenesis by counting the number of sub-intestinal vessels between the second and seventh intersegmental vessels and gene expression analysis of vascular endothelial growth factor (VEGF) and VEGF receptors at 72 hpf. SiO2 NPs did not show any adverse effects on survival rate, hatching time, gross morphology, or physiological angiogenesis. We found that SiO2 NPs were trapped by the chorion up until to the hatching stage. After chemical removal of the chorion (dechorionation), positively surface-charged SiO2 NPs (25 nm) significantly reduced the survival rate of the fish compared to the control group. These results indicate that zebrafish chorion acts as a physical barrier against SiO2 NPs, and removing the chorions in ZFET might be necessary for evaluation of toxicity of NPs.